Introduction
Antiepileptics are used for the prevention and control of seizures, with roles extending into psychiatric, neuropathic pain, and migraine management. Nirvana Pharma provides a wide range of classic and newer-generation AEDs (anti-epileptic drugs), ensuring availability for neurology clinics, hospitals, and long-term epilepsy management programs.
📋 Antiepileptic Product Catalogue
Classic Antiepileptics
| Drug Name | Common Strengths | Primary Uses |
|---|---|---|
| Phenytoin | Cap: 30, 100 mg; Chewable: 50 mg; Susp: 125 mg/5 mL; Inj: 50 mg/mL | Generalized tonic-clonic, focal seizures, status epilepticus |
| Carbamazepine | Tab: 100, 200 mg; CR: 200, 400 mg; Susp: 100 mg/5 mL | Focal, generalized tonic-clonic, trigeminal neuralgia, bipolar disorder |
| Oxcarbazepine | Tab: 150, 300, 600 mg; Susp: 300 mg/5 mL | Focal seizures |
| Valproic Acid / Divalproex | Tab/DR/ER: 125–500 mg; Syrup: 250 mg/5 mL | Focal, generalized, absence, myoclonic seizures; bipolar disorder, migraine prophylaxis |
| Phenobarbital | Tab: 15–100 mg; Elixir: 20 mg/5 mL; Inj: 65, 130 mg/mL | Generalized, focal seizures, status epilepticus |
| Primidone | Tab: 50 mg, 250 mg | Generalized tonic-clonic, focal seizures |
Newer Antiepileptics
| Drug Name | Common Strengths | Primary Uses |
|---|---|---|
| Lamotrigine | Tab: 25–200 mg; Chew/ODT: 2–25 mg | Focal, generalized, Lennox-Gastaut, bipolar disorder |
| Lacosamide | Tab: 50–200 mg; Soln: 10 mg/mL; Inj: 200 mg/20 mL | Focal seizures |
| Zonisamide | Cap: 25, 50, 100 mg | Focal, generalized seizures |
| Levetiracetam | Tab: 250–1000 mg; Soln: 100 mg/mL; Inj: 500 mg/5 mL | Focal, generalized, myoclonic |
| Brivaracetam | Tab: 10–100 mg | Adjunct in focal seizures |
| Topiramate | Tab: 25–200 mg; Sprinkle cap: 15, 25 mg | Focal, generalized, Lennox-Gastaut, migraine prophylaxis |
| Rufinamide | Tab: 200, 400 mg; Susp: 40 mg/mL | Lennox-Gastaut syndrome |
| Felbamate | Tab: 400, 600 mg; Susp: 600 mg/5 mL | Refractory seizures, Lennox-Gastaut |
| Perampanel | Tab: 2–12 mg | Focal, generalized tonic-clonic |
| Cannabidiol (Epidiolex) | Soln: 100 mg/mL | Lennox-Gastaut, Dravet syndrome, TSC |
Drugs for Absence & Myoclonic Seizures
| Drug Name | Common Strengths | Primary Uses |
|---|---|---|
| Ethosuximide | Cap: 250 mg; Syrup: 250 mg/5 mL | Absence seizures |
| Clobazam | Tab: 5–20 mg | Lennox-Gastaut, adjunct epilepsy |
| Clonazepam | Tab/ODT: 0.25–2 mg | Myoclonic, absence, Lennox-Gastaut |
Benzodiazepines for Acute Seizures
| Drug Name | Common Strengths | Primary Uses |
|---|---|---|
| Diazepam | Tab: 2–10 mg; Inj: 5 mg/mL; Rectal gel: 5–20 mg | Status epilepticus, seizure clusters |
| Lorazepam | Tab: 0.5–2 mg; Inj: 2–4 mg/mL | Status epilepticus, acute seizure control |
Adjuncts & Other Mechanisms
| Drug Name | Common Strengths | Primary Uses |
|---|---|---|
| Gabapentin | Cap/Tab: 100–800 mg | Focal seizures, neuropathic pain |
| Pregabalin | Cap: 25–300 mg | Adjunct focal seizures, neuropathic pain, GAD |
| Tiagabine | Tab: 2–12 mg | Adjunct focal seizures |
| Vigabatrin | Tab/Sachet: 500 mg | Infantile spasms, refractory focal seizures |
Closing Note
Nirvana Pharma’s antiepileptic portfolio balances proven classic drugs (phenytoin, carbamazepine, valproate) with modern therapies (levetiracetam, brivaracetam, cannabidiol). This ensures broad coverage of seizure types while supporting physicians in delivering individualized epilepsy management.